No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Christopher Lahey Promoted to Director of Operations of OKAY Industries

Editor: What To Know

  • , a contract manufacturer of components and subassemblies for global medical device Original Equipment Manufacturers (OEMs), is pleased to announce the promotion of Christopher Lahey to Director of Operations.
  • “I'm truly humbled for this leadership opportunity at OKAY and I'm eager to work with our employees in strengthening the OKAY Way culture as we execute our mission of pursuing the highest quality outcomes,” said Lahey.
  • His background in quality assurance has provided him with a comprehensive understanding of our customers' needs and will complement his forward vision for continuous improvement and operational excellence sought after by our customers,” said Sean Stowik, Director of Sales and Marketing.

OKAY Industries, Inc., a contract manufacturer of components and subassemblies for global medical device Original Equipment Manufacturers (OEMs), is pleased to announce the promotion of Christopher Lahey to Director of Operations.

Christopher Lahey will now oversee the daily manufacturing operations at OKAY Industries’ U.S. facilities in New Britain and Berlin, Connecticut, implementing best practices and ensuring timely production of the highest quality precision components. He will also support production activities for the Company’s Costa Rica facility.

Lahey brings more than 25 years of demonstrated experience in automotive and medical component manufacturing. A member of the OKAY team since 2011, Lahey previously held the positions of Quality Manager and Director of Quality Assurance.

“We are excited about Chris’ transition to this new role. His background in quality assurance has provided him with a comprehensive understanding of our customers’ needs and will complement his forward vision for continuous improvement and operational excellence sought after by our customers,” said Sean Stowik, Director of Sales and Marketing.

“I’m truly humbled for this leadership opportunity at OKAY and I’m eager to work with our employees in strengthening the OKAY Way culture as we execute our mission of pursuing the highest quality outcomes,” said Lahey.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy